No Data
No Data
Hang Seng Index: Benefiting from policy support, biotechnology stocks have seen three consecutive months of inflows.
The Hang Seng Index company stated that there are signs of improvement in the recent situation of biotechnology stocks, as well as benefitting from policy support and three consecutive months of inflow of funds.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. subscribed to a structured deposit product with a total amount of 0.2 billion yuan from Shanghai Pudong Development Bank.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) announced that on July 1, 2024, the company entered into a Pudong Development Bank structured deposit product agreement, agreeing to subscribe to a total amount of RMB 0.2 billion of structured deposit products using its own idle funds generated from daily operations.
Express News | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical - Agreed to Subscribe for Structured Deposit Product for RMB200 Mln
Shanghai Fudan-Zhangjiang Bio-pharmaceutical Co. Ltd. subscribed to a structured deposit product from Shanghai Pudong Development Bank with a total amount of 0.2 billion yuan.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349) announced that on July 1, 2024, the company signed a Pudong Development Bank structure ...
Express News | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd - Subscription of Structured Deposit Product Under Spd Bank
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) held a board of directors meeting on August 12 to review and approve its interim performance.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. (01349.HK) announced that it will hold a board of directors meeting on August 12, 2024 (Monday) to consider and approve (including) the unaudited interim performance of the company and its subsidiaries for the six months ended June 30, 2024 and the declaration of interim dividends (if any).
No Data